Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03450967

Recruitment Status : Unknown

Verified August 2021 by Myung-Ju Ahn, Samsung Medical Center.
Recruitment status was: Active, not recruiting

First Posted : March 1, 2018

Last Update Posted : August 10, 2021

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Myung-Ju Ahn, Samsung Medical Center

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Actual Primary Completion Date :	June 30, 2021
Estimated Study Completion Date :	March 2022

To Top